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ABSTRACT  
Biofortification of staple crops with provitamin A (PVA) carotenoids is an innovative 
strategy for controlling vitamin A (VA) deficiency in low-income countries (LIC). Plant 
breeding programs have been successful in developing biofortified varieties of cassava, 
maize, and orange-fleshed sweet potatoes that contain amounts of PVA-carotenoids that 
have the potential to impact VA status in human populations. Nutrition studies indicate 
that beta-carotene in biofortified staple crops is converted efficiently to VA in the body. 
Randomized, controlled, community-based efficacy and effectiveness trials have been 
conducted to assess the effect of regular consumption of PVA-carotenoid biofortified 
staple crops on VA status. Results indicate that regular consumption of biofortified staple 
crops increases plasma beta-carotene concentrations consistently, but has a moderate 
effect, or no effect, on VA status, when assessed by serum retinol concentration, breast 
milk retinol concentration, or total body VA stores. Studies are currently underway to 
further investigate whether consumption of biofortified staple crops improves VA status 
in population subgroups at risk of VA deficiency, and to better understand how to 
optimize the biological impact of these interventions in resource-poor settings.  
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INTRODUCTION 
 
Increasing the provitamin A (PVA)-carotenoid content of staple crops is an innovative 
strategy for controlling vitamin A (VA) deficiency among high-risk populations in the 
developing world. The primary focus of breeding programs to date has been to identify 
varieties that are rich in beta-carotene, which has roughly twice the VA activity of other 
PVA-carotenoids based on its chemical structure. Orange-flesh sweet potatoes (OSP) 
were the first of the biofortified crops to be released. Initial carotenoid-rich cultivars were 
released in 2002 and OSP are currently available through agricultural extension workers 
or community-based programs in 21 countries. Current varieties provide 30-100 μg beta-
carotene/g OSP. Even a small piece of OSP — such as what a child might consume as a 
snack — can therefore contribute substantially to dietary VA intakes. Biofortified 
cassava and biofortified maize were released in 2011-12 and are currently available in 
five countries [1]. While breeding programs have met their targets of 15 μg beta-carotene 
equivalents/g crop, released varieties currently provide only ~5-10 μg/g. As breeders 
have sought to improve carotenoid profiles and agronomic properties of the PVA-
carotenoid biofortified crops, nutrition research has proceeded to investigate the 
bioavailability and bioconversion of beta-carotene from these staple foods. Furthermore, 
human studies are accumulating evidence on the potential impact of regular biofortified 
crop consumption on VA status among groups at risk of deficiency. 
 
VA Equivalency of PVA-carotenoids in Biofortified Crops 
To assess whether PVA-biofortified crops are likely to have an impact on the VA status 
of human populations, it is important to know whether the beta-carotene in biofortified 
crops is bioavailable and converted to VA in the body. A VA equivalency factor of 12:1 
(12 µg beta-carotene=1 µg retinol) has been established for beta-carotene from fruits and 
vegetables in mixed diets [2]. Several small studies have been carried out to assess the 
VA equivalency of beta-carotene in PVA-biofortified cassava and biofortified maize, by 
measuring beta-carotene and retinyl ester concentrations in the triglyceride-rich 
lipoprotein fraction of plasma (TRL-plasma) after consumption of biofortified foods. 
Because TRL-plasma is the fraction of the plasma that contains newly absorbed 
carotenoids and newly formed retinyl palmitate, analysis of postprandial TRL-plasma 
allows the effects of a single dose of beta-carotene to be assessed.  
 
The bioavailability and VA equivalency of beta-carotene in biofortified cassava was 
assessed in two studies in US women (Table 1) [3, 4]. Women received single meals 
containing three different portions of cassava porridge, known as gari, which is an 
important fermented staple food in Sub-Saharan Africa. Because the bioavailability of 
PVA is influenced by fat content, the meals were prepared with varying amounts of fat 
to determine its influence on bioavailability in the different porridge preparations. The 
cassava meals were provided in random order, separated by 2 weeks. In the first study, 
women received: 1) biofortified cassava porridge with 20 g fat, 2) biofortified cassava 
porridge with 6 g fat, and 3) non-biofortified cassava porridge with a reference dose of 
preformed VA [3]. In the second study, women received: 1) biofortified cassava gari, 2) 
non-biofortified cassava gari blended with red palm oil (containing beta-carotene), and 
3) non-biofortified cassava gari with a reference dose of preformed VA [4]. TRL-plasma 
concentrations of retinyl esters increased in response to consumption of both biofortified 
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cassava porridge and gari, and the VA equivalencies of beta-carotene in porridge and gari 
were estimated as ~4.4:1 and 4.2:1, respectively. Additional dietary fat did not affect 
estimates of VA equivalency, suggesting that 6 g fat/meal is sufficient for optimal 
absorption of beta-carotene [4]. 
 
The bioavailability and VA equivalency of beta-carotene in biofortified maize was 
assessed in US women and in Zimbabwean men (Table 1) [5, 6]. Women received single 
meals containing three different maize porridges, in random order, separated by two 
weeks: 1) biofortified maize porridge, 2) non-biofortified maize porridge with a reference 
dose of beta-carotene, and 3) non-biofortified maize porridge with a reference dose of 
preformed VA [5]. TRL-plasma concentrations of retinyl esters increased in response to 
consumption of biofortified maize porridge, and the VA equivalence of beta-carotene was 
estimated as 6.8:1. In Zimbabwe,  men received a single meal of [2H]-labeled biofortified 
maize with 20 g butter, followed by a reference dose of 13C10-labeled retinyl acetate 8 
days later [6]. Serum enrichments of [2H]-retinol increased, and the VA equivalency of 
beta-carotene was estimated as 3.2:1. Collectively, these results indicate that beta-
carotene from biofortified cassava and maize is converted efficiently to VA in the body, 
and suggest that regular consumption of these biofortified foods could have a positive 
impact on VA status in human populations.  
 
In a community setting in Zambia, the VA equivalency of PVA-carotenoids from 
biofortified maize in a 90-day feeding trial was estimated as 10.4:1, by comparing the 
mean change in total body VA stores assessed by the retinol isotope dilution test [7] in 
children who consumed either biofortified maize with a placebo dose, or non-biofortified 
maize with a VA dose [8]. Stable isotope dilution techniques allow for an estimation of 
the body’s exchangeable pool of VA to be calculated from the ratio of labeled to non-
labeled retinol in plasma or serum following the administration of a stable isotope-
labeled VA dose. Because stable isotope dilution enables an estimation of total body VA 
stores, it is considered to be a more sensitive method for determining VA status in groups 
of subjects [7].   
 
Variability in VA equivalency among studies may be related to differences in diet- and 
host-related factors that can potentially affect bioavailability and/or bioconversion of 
PVA-carotenoids, such as dietary fat and fiber in mixed-meals; amount of beta-carotene 
in a meal; gastrointestinal illnesses; VA, iron, and/or zinc status; and/or genetic 
polymorphisms of the gene that encodes -carotene dioxygenase, which can reduce 
bioconversion of beta-carotene to VA in the body [9].   
 
Efficacy and Effectiveness of PVA-biofortified Crops for Improving VA Status 
The efficacy of regular consumption of PVA-biofortified cassava and maize for 
increasing VA status has been assessed in community settings in LIC. Kenyan 
schoolchildren were randomly allocated to receive daily, 6 days/week, for 18.5 weeks 
either: 1) non-biofortified cassava with a placebo supplement, 2) biofortified cassava 
with a placebo supplement, or, 3) non-biofortified cassava with a beta-carotene 
supplement [10]. As a primary outcome, serum retinol concentrations were assessed, 
while hemoglobin and serum beta-carotene concentrations were assessed as secondary 
outcomes. Consumption of biofortified cassava resulted in a large increase in serum beta-
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carotene concentration, and a significant, modest gain in serum retinol concentration, but 
had no effect on hemoglobin concentration or the prevalence of low serum retinol 
concentrations (<0.70 µmol/L). These results indicate that while beta-carotene was well-
absorbed, bioconversion of beta-carotene to retinol was less than optimal. In Nigeria, a 
randomized, community-based trial is currently underway to assess the efficacy of 
biofortified cassava for improving the VA status of preschool-age children. As a primary 
outcome, change in total body VA stores, which is considered to be a more sensitive 
indicator of VA status than serum retinol concentrations, will be assessed using retinol 
isotope dilution; results are anticipated in 2017 [11]. 
 
In 2010 [12] and 2012 [8], two randomized, controlled efficacy studies were performed 
in the Eastern Province of Zambia. The first study fed biofortified maize compared with 
non-biofortified maize to three to five year old children for 70 days, and evaluated 
changes in VA status with the modified relative dose response (MRDR) test [12]. The 
MRDR test requires one blood draw after a dose of 3,4-didehydroretinyl acetate (DRA) 
to human subjects. The MRDR test can be used as a qualitative indicator of liver stores 
of VA because the test operates on the fact that as VA liver reserves become low, retinol 
binding protein accumulates; therefore, after a single oral dose of DRA, the 3,4-
didehydroretinol from hydrolysis of DRA binds to accumulated RBP and is rapidly 
released into the serum after which it can be measured by HPLC. On the background of 
the high-dose VA supplement program, both groups lost VA stores during the 
intervention. This study was followed by a placebo-controlled trial that included 
biofortified maize with much higher PVA carotenoid content, a longer feeding period 
(90 days), and total body VA stores assessed using a retinol isotope dilution technique as 
the primary VA status outcome in five to seven year old children who were no longer 
eligible for the high-dose VA supplementation program [8]. Non-parametric analysis 
showed that consumption of biofortified maize improved total body VA stores as 
effectively as a VA supplement, and VA stores were significantly greater in both the 
biofortified maize and VA groups than in the group that did not receive any VA during 
the intervention.  
 
A series of trials were carried out in Zambia to assess the public health impact of 
biofortified maize consumption, incorporating both multiple target groups and indicators 
of VA status. The first of these, conducted from 2012-13, was a cluster-randomized 
controlled trial of preschool-aged children [13]. It was designed to test whether regular 
consumption of biofortified maize, compared to conventional white maize, could shift 
the population distribution of serum retinol as has been shown previously with industrial 
food fortification [14]. While this six-month intervention did significantly improve 
children’s serum beta-carotene concentrations, it failed to show an effect on serum 
retinol. The lack of effect has been attributed primarily to the relative adequacy of VA 
status in children in this age group (4-8 y), potentially as a result of exposure to high-
dose VA supplements every six months. A 2013 trial at this same research site considered 
the impact of a short-term feeding intervention with either 1) biofortified maize with a 
placebo capsule, 2) non-biofortified maize with a VA capsule, or 3) non-biofortified 
maize with a placebo capsule, targeting lactating mothers [15]. As infants are born with 
low stores of VA, adequate VA concentrations in breast milk are crucial for infant health 
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and nutrition [16]. Breast milk retinol is therefore a highly relevant indicator for public 
health. This three week intervention increased plasma beta-carotene concentrations, but 
had no effect on plasma or milk retinol concentrations. However, there was a significant 
downward trend in the prevalence of low milk retinol concentrations in the VA and 
biofortified maize groups compared to the control group. The final trial in this series is a 
mother-baby feeding trial, where a cohort of infants is being followed from receipt of 
their six-month high-dose VA capsule through their first birthday. Starting at 9 months 
of age, infants and their mothers received twice-daily meals of either 1) non-biofortified 
maize, 2) biofortified maize, or 3) preformed VA fortified maize [17]. As a primary 
outcome, this trial will measure the change in infants’ total body VA stores, which are 
dependent on VA intake both from breast milk and from complementary foods; results 
are anticipated in 2017. 
 
The effectiveness of two large-scale OSP programs for improving VA status was 
assessed in Mozambique and Uganda [18, 19]. The programs promoted household 
production and consumption of OSP, and included nutrition education. In Mozambique, 
after two years of intervention, mean serum retinol concentrations measured in dried 
blood spots increased significantly, and the prevalence of low serum retinol 
concentrations (<0.70 µmol/L) decreased in children in OSP households compared to 
control households [18]. In Uganda, the intervention had no impact on serum retinol 
concentration, or the prevalence of low serum retinol concentrations, in children three to 
five years of age, after two years of intervention. However, when the analysis was 
restricted to children with complete data on important covariates, the prevalence of serum 
retinol concentrations <1.05 µmol/L decreased significantly in children in OSP 
households compared to children in control households. The intervention had no impact 
on maternal serum retinol concentration, or the prevalence of serum retinol 
concentrations <1.05 µmol/L, possibly because their VA status was adequate at baseline 
[19].  
In an OSP feeding study in South Africa, school-age children were fed a morning OSP 
snack or an equal amount of white-fleshed sweet potato (WSP) before lunch in a 
controlled environment for 53 school days [20]. The OSP group had a significantly 
greater improvement in liver VA stores compared with the control group in response to 
the intervention, which was evaluated with the MRDR test. 
 
The efficacy of consumption of biofortified OSP for improving VA status in women of 
reproductive age was assessed in a community-setting in Bangladesh [21]. Women with 
marginal VA status were randomly assigned to receive, six days/week for ten weeks, 
either 1) non-biofortified WSP with a placebo capsule, 2) boiled biofortified OSP with a 
placebo capsule, 3) fried biofortified OSP with a placebo capsule, or 4) boiled non-
biofortified WSP with a VA capsule. Regular consumption of OSP increased plasma 
beta-carotene concentration significantly, and the increase tended to be greater with 
added dietary fat (fried OSP vs. boiled OSP). Despite the increase in plasma beta-
carotene, the intervention had no effect on VA status, assessed by serum retinol 
concentration and total body VA stores, suggesting the conversion of beta-carotene to 
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A similar study assessed the efficacy of consumption of biofortified OSP for improving 
VA status in lactating women in Bangladesh [22]. Women were randomly assigned to 
receive six days/week for three weeks, either 1) non-biofortified WSP with a placebo 
capsule, 2) biofortified OSP with a placebo capsule, or 3) non-biofortified WSP with a 
VA capsule. Short-term consumption of biofortified OSP increased plasma beta-carotene 
concentration significantly, but had no impact on serum or milk retinol concentrations, 
as was observed for non-lactating women.  
 
In summary, regular consumption of PVA-carotenoid biofortified crops has the potential 
to improve VA status in populations in LIC; however, the impact of interventions on VA 
status has been inconsistent. Although consumption of biofortified staple crops increased 
plasma beta-carotene concentration consistently, the interventions had a moderate effect, 
or no effect on serum retinol concentrations. Serum retinol is currently considered by the 
WHO to be appropriate  for assessing population VA status and evaluating the effects of 
interventions when the population has a marginal or low VA status [23, 24]. However, 
serum retinol concentrations are homeostatically controlled, and therefore may not 
always change in response to an intervention. Lack of conversion of beta-carotene to VA 
may be related to VA status, and other host- or diet-related factors. Studies are underway 
to further investigate the potential for these interventions to improve VA status in 
populations at risk of VA deficiency, using multiple biochemical and functional 
indicators of VA status, and to better understand how to optimize the biological impact 
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Table 2.1: Estimates of VA Equivalency of beta-carotene from Biofortified Cassava and Biofortified Maize 
Study population, 
n, reference 
VA status  
at baseline 
Biofortified crop, duration of 
supplementation 
Method for estimating VA equivalency VA equivalency ratio 
(µg beta-carotene:µg retinol) 




100 g of cassava porridge (2 mg 
beta-carotene) as a single meal 
containing 20 g fat 
Comparison of retinyl esters in TRL 
plasma in response to biofortified cassava 
vs reference dose of VA (0.3 mg) 
4.2:1 (SD 3.1) 




100 g of cassava porridge (2 mg 
beta-carotene) as a single meal 
containing 6 g fat 
Comparison of retinyl esters in TRL 
plasma in response to biofortified cassava 
vs a reference dose of VA (0.3 mg) 
4.5:1 (SD 3.1) 




200-226 g of cassava gari (1 mg 
beta-carotene) as a single meal 
containing 9 g fat 
Comparison of area under the curve for 
retinyl palmitate in TRL plasma in 
response to biofortified cassava vs a 
reference dose of VA (0.3 mg)  
4.2:1 (SD 1.5) 




250 g maize porridge (527 µg 
beta-carotene), as a single meal 
containing 8 g fat 
Comparison of retinyl esters in TRL 
plasma in response to biofortified maize vs 
reference dose of VA ( 286 µg RAE) 
6.5:1 (SD 3.5) 
Zimbabwean men, 40-




300 g maize 
porridge,intrinsically labeled 
with 2H (1.2 mg [2H]-beta-
carotene) containing 20g fat 
Comparison of retinol formed from 
[2H]beta-carotene vs reference dose of 
[13C10]-retinyl acetate 
3.2:1 (SD 1.5) 
Zambian children, 
5-7 y, n = 133, [8] 
Adequate 
SR:0.98 ± 0.27 
µmol/L1 
200 g maize/d for 90 d (18 µg -
carotene equivalents/g maize) 
Comparison of total body VA stores among 
children fed orange maize and placebo, 
white maize and a placebo, or white maize 
and a VA supplement (0.4 mg) 
10.4:1 
VA=vitamin A; NR=not reported; TRL=triglyceride rich lipoprotein; SD=standard deviation; SR=serum retinol 
1mean ± SD 
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Table 2.2: Effect of Consumption of PVA-biofortified Crops on VA status in Community-based Studies 
Study population, 
age, n, reference 

















375 g/d cassava  
(1,460 μg beta-
carotene/d), 6 d/wk 
for 18.5 wk 
Change in serum retinol and serum 
beta-carotene concentrations in 
biofortified cassava group vs. non-
biofortified cassava group  
Significant intervention effect on serum retinol +0.04 
µmol/L (95% CI: 0.00, 0.07 µmol/L) and on serum 
beta-carotene (524% increase (448, 608%)); No effect 
on prevalence of low serum retinol concentrations  
Zambian children, 




11.8% with low 
liver VA stores1 
~150 g  maize as 2 
meals/d, 6 d/wk for 
a total of 70 d 
Change in MRDR response (liver 
VA stores1) in biofortified vs. non-
biofortified maize groups 
No effect on liver VA stores2; No effect on serum 
retinol concentration 
Zambian children, 5-




total body VA 
stores2 
200 g maize as 3 
meals/d (18 µg -
carotene 
equivalents/g 
maize), 6 d/wk for 
90 d 
Change in total body VA stores2 in 
biofortified maize vs. non-
biofortified maize 
Significant effect on total body VA stores; No effect 
on serum retinol concentration 
Zambian children, 4-




SR:0.98 ± 0.27 
μmol/L 
(mean±SD) 
200 g maize as 2 
meals/d, 6 d/wk for 
6 mo; orange maize 
provided 3 mg beta-
carotene/d  
Endline serum beta-carotene and 
retinol concentrations and endline 
deficiency prevalence (serum 
retinol <0.70 μmol/L) in 
biofortified maize group vs. non-
biofortified maize group 
Significant effect on serum beta-carotene; No effect on 
serum retinol, or prevalence of low serum retinol 
concentrations 
Zambian lactating 
women, 18-35 y of 





287 g maize as 2 
meals/d, 6 d/wk for 
3 wk; orange maize 
Change in plasma and milk retinol 
concentrations in biofortified 
maize group vs. non-biofortified 
maize group 
Significant effect on plasma beta-carotene; No effect 
on plasma or milk retinol; significant downward trend 
in prevalence of low milk retinol concentration in the 
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(geometric 
mean); 31.1% 
with PR <1.05 
μmol/L 
provided ~5.2 mg 
beta-carotene/d  
biofortified maize and VA capsule groups compared 
to the non-biofortified maize group 
Mozambican 
children, mean age: 
17.4 months, n=733, 
[18] 
Marginal 
SR: 0.57 µmol/L 






Change in prevalence of low 
serum retinol concentration 
(<0.70 µmol/L) in children in 
OSP program area vs. in children 
in control area without OSP 
program 
Significant reduction in prevalence of low serum 
retinol concentration 
Ugandan children, 












Change in prevalence of low 
serum retinol concentration 
(<1.05 µmol/L) in children in 
OSP program area vs. in children 
in control area without OSP 
program  
Significant reduction (9.5 percentage points) in 
prevalence of low serum retinol concentration, in a 
subset of children with complete data on confounding 
factors 
Ugandan women 












Change in prevalence of low 
serum retinol concentration 
(<1.05 µmol/L) in women in OSP 
program area vs. the control area  
No effect on prevalence of low serum retinol 
concentration  
South African 
children, 5-10 y of 
age, n=180, [20] 
Marginal, 14-22% 
with low liver VA 
stores1 
125 g OSP for 53 
school days 
Change in MRDR response (liver 
VA stores1) OSP vs. WSP group. 
Significant effect on liver VA stores2  
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Bangladeshi women, 
27 ± 1.3 y of age, 
n=120, [21] 
Marginal 
SR: >0.70 to 
≤1.05 µmol/L, by 
design 
~128 g OSP 
(~7200 µg/d beta-
carotene), 6 d/wk 
for 10 wk 
Change in plasma beta-carotene 
and retinol concentrations, and 
total body VA stores1, in women 
in OSP groups (with and without 
added dietary fat) vs. WSP group 
Significant effect on plasma beta-carotene 
concentration; No effect on plasma retinol 
concentration; No effect on total body VA stores 
Bangladeshi 
lactating women, 
18-37 y of age, 
n=135, [22] 
Marginal 
SR:>0.70 to <1.05 
µmol/L, by design 
~ 200 g/d OSP (12 
mg/d beta-
carotene), 6 d/wk 
for 3 wk 
Change in serum beta-carotene 
and retinol concentrations, and 
breast milk beta-carotene and 
retinol concentrations in OSP 
group vs WSP group 
Significant effect on plasma beta-carotene 
concentration; No effect on serum retinol 
concentration; No effect on milk retinol 
concentration); No effect on milk beta-carotene  
VA=vitamin A; SR=serum retinol; PR=plasma retinol; SD=standard deviation; OSP=orange-fleshed sweet potato; WSP=white-fleshed 
sweet potato; MRDR=modified relative dose response. 
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